Using 3D bioprinting, researchers have developed a more effective method for testing potential HSV treatments.

Theralase validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the ...

This Press Release updates numerical list in reference sectionTheralase® validates previous University of Manitoba research ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of ...

The overall market of herpes simplex is expected to boost with the expected launch of emerging therapy, increased awareness, and extensive research in the forecast period (2025-2034). LAS ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ACCES ...

In a human cell-based brain model, repetitive physical injuries reactivate the common virus, Herpes Simplex Virus 1 (HSV-1), ...

Genital herpes simplex virus (HSV) infections are frequently asymptomatic or undiagnosed, but more than half the US population is seropositive for HSV, and about one-fifth are positive for HSV-2.

Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...

Mashable is a global, multi-platform media and entertainment company.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

The possibility that Alzheimer’s disease diagnosis is associated with viruses, bacteria, fungi, and parasites has been postulated over the past three decades. (L-R) In green - herpes virus proteins.